drugset / Trial / NCT00721877

Resveratrol in Healthy Adult Participants

NCT00721877

Phase 1 Completed 42 enrolled National Cancer Institute (NCI)
NaSingle-groupOpen-labelPrevention

Summary

Resveratrol may prevent cancer in healthy people. Studying samples of blood and urine in the laboratory from participants who are taking resveratrol may help doctors learn more about how this drug is used by the body. This phase I trial is studying the side effects of resveratrol and to see how it works in healthy adult participants.

Timeline

Start
2008-08
Primary completion
2009-07
Completion
2009-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Resveratrol Small molecule Oral

Indications

No indication recorded.